Trial Profile
Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica: a Double Blind Placebo Controlled Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Polymyalgia rheumatica
- Focus Therapeutic Use
- 29 Aug 2011 New trial record